day 1 agenda

12th Global Insight Conference on Breast Cancer 
Day -1: July(07, 2025)
Meeting Hall-I
Registrations Open (08:00-08:45)
Opening Ceremony (08:45-09:00)
Moderator
Jessica Burgers, Holy Cross Health, USA
Keynote Talks
09:00-09:30 Title: TFEB is a master regulator of tumor-associated macrophages in breast cancer
Daping Fan, University Of South Carolina, USA
 
09:30-10:00 Title: Context-Responsive Nanomedicine in Targeted CRISPR/Cas9 Therapy for Basal Like Breast Cancer
Dipanjan Pan, The Pennsylvania State University, USA
   
10:00-10:30 Title: Distinct Tumor Immune Responses to Nanosecond Pulsed Electric Fields (nsPEFs) Determine Immunity
Stephen Jack Beebe, Old Dominion University, USA
   
 Group Photo
10:30-10:45 ---Refreshment Break @ Foyer  
   
SCIENTIFIC SESSION-I

Session Chair: Hanna Romanska-Knight, Medical University of Lodz, Poland

 
   
10:45-11:05 Title: Modern Management of the Axilla in Breast Cancer
Rizzo Monica, Emory University School of Medicine, USA
   
11:05-11:25 Title: Breast Cancer Screening in the Elderly United States Population: Challenges and Future Considerations
Jessica Burgers, Holy Cross Health, USA
   
11:25-11:45 Title: Comparing Narrow and Wide Angle Digital Breast Tomosynthesis
Tanya W. Moseley, The University of Texas MD Anderson Cancer Center, USA
   
11:45-12:05 Title: The Molecular Mechanisms behind Advanced Breast Cancer: Metabolic Reprogramming and Alternate Translation
Columba De La Parra, Lehman College- City University of New York, USA
   
12:05-12:25 Title: The effect of deuterium depletion on the survival outcomes of cancer patients and recurrence of the disease
Gábor Somlyai, HYD LLC for Cancer Research and Drug Development, Hungary
   
12:25-12:45 Title: Anticancer Potential of Black Ginseng Extract in a Breast Cancer Cell Xenograft Mouse Model   
Hye Jin Park, Kangwon National University, South Korea
 
  Networking & Panel Discussion
12:45-13:45  Lunch Break @ Restaurant 
SCIENTIFIC SESSION-II

Session Chairs:
Dipanjan Pan, The Pennsylvania State University, USA
&
Amy S. Yee, Tufts University School of Medicine, USA
   
13:45-14:05 Title: The Wu-Kolassa Estimator in Restricted Mean Survival Time Analysis: Reducing Bias and Enhancing Power in Oncology Survival Studies
Yaoshi Wu, AstraZeneca, USA
   
14:05-14:25 Title: The Revolution in Understanding Breast Cancer Recurrences
Howard Petty, University of Michigan, USA
 
14:25-14:45 Title: Technological Innovations Enable the 24-hour Discharge of Patients Who Undergo Endoscopic Nipple-Sparing Mastectomy and Direct-to-Implant Breast Reconstruction: Safety and Aesthetic Outcomes from A Single-Centre, Prospective Cohort Study
Zhenggui Du, West China Hospital of Sichuan University, Sofia, China
   
14:45-15:05 Title: A Precision engineered approach based on modular assembly for in vitro expansion of low-abundance antigen-specific T cells   
Zhangyong Hong, Nankai University, China
   
15:05-15:45 Title: Can Fraction-B from Catfish Skin be Used Successfully for the Treatment of Breast Cancer and for Healing Wounds Cosmetically After Breast Cancer Surgery?
Jassim M. H. AlMohammad Ali, Abdullah AlSalem University, Kuwait
 
15:45-16:05 Title: Postoperative outcomes of minimally-invasive nipple-sparing mastectomy with immediate breast reconstruction versus conventional approach in women with early breast cancer – a single centre experience
Marc Ong Weijie, Khoo Teck Puat Hospital, Singapore
   
16:05-16:15  Refreshment Break
   
16:15-16:35 Title: FGF/FGFR-Signaling in response to therapy in triple-positive breast cancer
Hanna Romanska-Knight, Medical University of Lodz, Poland
   
16:35-16:55 Title: MEMS-based biochips for electro-thermo-mechanical (ETM) phenotyping of breast biopsy tissues
Hardik Jeetendra Pandya, Indian Institute of Science, Bangalore, India
   
16:55-17:15 Title: Hypoxia modulates the XBP1s/HDAC2/EZH2-ΔNp63α axis to promote breast cancer metastasis independent of HIF1α
Zhixiong Jim Xiao, Sichuan University, China
   
17:15-17:35 Title: The regulation of the triple-negative breast cancer microenvironment by the CD74/CD84-induced cascade   
Idit Shachar, Weizmannn Institute of Science, Israel
   
  Networking & Panel Discussion
Day-1 Concludes
If any one interested to attend the conference or to book your speaker slot, please send an email to breastcancer@innovinc.org 

day 2 agenda

Day -2: July(08, 2025)
Meeting Hall-I
Moderator
Izabela M?ynarczuk-Bia?y, Warsaw Medical University, Poland
Keynote Talks
09:15-09:45 Title: Radioguided occult lesion localisation for non-palpable breast lesions in combination with radioisotope sentinel lymph node localisation (SNOLL) – 10 year experience of a single centre
Maged Hussien, Norfolk and Norwich University hospital, United Kingdom
 
09:45-10:15 Title: Poor oral health and cancer – why does it matter?
Jukka H. Meurman, University of Helsinki and Helsinki University, Finland
   
10:15-10:45 Title: The Luminous Pro Series (LPS Pink Luminous Breast), an LED-based technology utilizing patented red light wavelengths between 620–800 nanometers, demonstrated comparable sensitivity and specificity to mammography in detecting breast abnormalities
Marylin R Dans, Silkprousa, USA
   
10:45-11:00  Refreshment Break
SCIENTIFIC SESSION-III

Session Chairs: Halina Abramczyk, Lodz University of Technology, Poland
&
YuTe Liu, Chung Shan Medical University, Taiwan
   
11:00-11:20 Title: Identification of Novel Markers for TTK Inhibitor and Taxane Sensitivity in Triple-Negative Breast Cancer
Lei Duan, Rush University Medical Center, USA
   
11:20-11:40 Title: In vitro and in vivo effects of A traditional Chinese medicine (TCM) in human breast cancer cells
YuTe Liu, Chung Shan Medical University, Taiwan
 
11:40-12:00 Title: Growth inhibitory effect of Leptospermum scoparium (manuka) chloroform extract on breast and liver cancer cell lines
Mohammed Musa Yahya Alzahrani, Imam Mohammad Bin Saud Islamic University, Saudi Arabia
   
12:00-12:20 Title: Prevalence of Epidermal Growth Factors Receptors in Iraqi Patients with Non-Small Cell Lung Cancer
Saad Alomar, College of Medicine-University of Basra, Iraq
 
12:20-12:40 Title: Lumpectomy surgery for large ductal carcinoma in situ
Jacqueline Tsai, Stanford University School of Medicine, USA
 
12:40-13:00 Title: Entosis in breast cancer as regulated process depending on stage of cancer
Izabela M?ynarczuk-Bia?y, Warsaw Medical University, Poland
 
Networking & Panel Discussion
13:00-13:50  Lunch Break @ Restaurant 
13:50-14:40  Poster Presentations
GICBC-101 Title: Spermidine potentiates anti-tumor immune responses and immunotherapy sensitivity in breast cancer
Wenfeng Zeng, Sun Yat Sen University, China
 
GICBC-102 Title: Case report of synchronous triple primary malignancies: bilateral breast cancer and rectal adenocarcinoma
Chiaching Yu, Taipei City Hospital, Taiwan
 
GICBC-103 Title: RGS4 and αSMA-expressing CAFs mediate immune escape via immunosuppressive mesenchymal network formation
Huiping Chen, Sun Yat Sen University, China
   
GICBC-104 Title: Application of artificial intellingence in cardio-oncology imaging for canver therapy-related cardiovascular toxicity: systematic review
Mohammed Hassan A Obaidan, Johns Hopkins Aramco Healthcare/ University College Dublin, Saudi Arabia
   
GICBC-105 Title: Wild-Type p53 Restrains CIP4 to Suppress Breast Cancer Metastatic Risk
Sohidul Islam, Academy of Scientific and Innovative Research, India
 
SCIENTIFIC SESSION-IV

Session Chairs: Lei Duan, Rush University Medical Center, USA
&
Mohammed Musa Yahya Alzahrani, Imam Mohammad Bin Saud Islamic University, Saudi Arabia
 
14:40-15:00 Title: Detection of Circulating Tumor Cells by Cell Block Technique in Malignant Tumors       
Jahnvi Vijay, Rajiv Gandhi University of Health Sciences, India
 
15:00-15:20 Title: A new modality for cancer tracking - Raman imaging, nanoIR imaging, fluorescence and AFM studies combined with AI analysis   
Halina Abramczyk, Lodz University of Technology, Poland
 
15:20-15:40 Title: An Epigenetics-Plus Combinatorial Therapy That Enables Immune Checkpoint Susceptibility as a Novel Cold-to-Hot Drug.      
Amy S. Yee, Tufts University School of Medicine, USA
 
15:40-16:00 Title: Synergistic Action of Benzyl Isothiocyanate and Sorafenib in a Nanoparticle Delivery System for Enhanced Triple-Negative Breast Cancer Treatment
Qi Wang, University of East Anglia, UK
   
16:00-16:20  Refreshment Break
 
16:00-16:20 Title:  Dissecting the Oncogenic Circuitry of miR-99b-5p in Breast Cancer: From Targetome to Tumor Regression
Bala Gür Dedeoglu, Ankara University, Turkey
 
16:20-16:40 Title: Expanding theranostics with ultrasound-mediated oncolytic virotherapy: at the crossroads of image guided gene therapy & immunotherapy to combat triple negative breast cancer
Candace Howard-Claudio, University of Mississippi Medical Center, USA
 
16:40-17:00 Title:  Taking one more innovative step forward. Use of deepithelialized axio-perforator, bipedicled flap for immediate combined breast/nac reconstruction
Vagif Kalender (Galandarov), Azerbaijan Medical University, Azerbaijan
 
  Networking & Panel Discussion
Closing Ceremony
If any one interested to attend the conference or to book your speaker slot, please send an email to breastcancer@innovinc.org 

Virtual agenda

Day -2: July 08th, 2025
Time Zone: Central European Time (CET)
Virtual Presentations
07:45-08:05 Title: Breast cancer survivors, psychological distress and quality of life: a multifaceted model of healthcare 
Syeda Zakia Hossain, The University of Sydney, Australia
   
08:05-08:25 Title: Introducing Cosmosort: The Next Generation Spatial Cell Sorter
Haewook Jang, Meteorbiotech, South korea
   
08:25-08:45 Title: One stage single port endoscopic breast cancer reconstruction with Bra-flap technique and direct to implant : a four-year case series report of SmoothSilk implant
Tsung Chun Huang, China Medical University Hospital, Taiwan
   
08:45-09:05 Title: Potential of epithelial membrane protein 3 as a novel therapeutic target for human breast cancer
Nan-Haw Chow, China Medical University Hospital, Taiwan
   
09:05-09:25 Title: Microwave ablation treatment of non-lactating mastitis
Aili Saiding, Guangyuan Central Hospital, China
   
09:25-09:45 Title: The identification and potential mechanism of SET7/9 as a tumor biomarker in breast cancer
Wenzhe Si, Peking University Third Hospital, China
   
09:45-10:05 Title: CanAssist Breast: First Proteomics and Artificial Intelligence Based Cost-effective Prognostic Test: Real world data 
Manjiri Bakre, OncoStem Diagnostics Pvt Ltd, India
   
10:05-10:15 Title: SDG like Bioactive Constituent of C. gouriana Exhibits Anticancer Potential in Breast Cancer Cells      
Reena Jassal, Punjabi University, India
   
10:15-10:25 Title: Comparative Evaluation of Biological Activity of Anti-Breast Cancer Monoclonal Antibodies
Harish Chander, National Institute of Biologicals, India
   
10:25-10:45 Title: The impact of bitter taste genes TAS2R38 and CA6 and breast cancer risk
Dorota Lukasiewicz-Smietanska, National Research Institute, Poland
   
10:45-11:05 Title: Automatic detecting multiple bone metastases in breast cancer
Yali Xu, Peking Union Medical College Hospital, China
   
11:05-11:25 Title: Efficacy and safety of robotic-assisted versus endoscopic-assisted axillary lymph node dissection in node-positive breast cancer: a retrospective comparative study
Haiyan Li, The Sixth Affiliated Hospital of Sun Yat-sen University, China
   
11:25-11:45 Title: Factors Influencing Adherence to Endocrine Therapy After Breast Cancer Surgery   
Aina Johnsson, Karolinska Institutet, Sweden
   
11:45-12:05 Title: Metabolome-Microbiome cross-talk in CRD-induced mammary tumorigenesis
Tapasree Roy Sarkar, Texas A & M University, USA
   
12:05-12:25 Title: Radiomics and Machine Learning for Preoperative Differentiation of In Situ and Invasive Breast Cancer Using DCE–MRI
Luana Conte, University of Palermo, Italy
   
12:25-12:45 Title: Toll-like Receptor 2-targeted therapies ameliorate the efficacy of chemotherapy and immunotherapy in breast cancer
Laura Conti, University of Torino, Italy
   
12:45-13:05 Title: Curcumin and doxorubicin delivered by biocompatible clay-based nanomaterials to overcome multidrug resistance in breast cancer
Paola Poma, University of Palermo, Italy
   
13:05-13:25 Title: Sleep, physical activity, and sedentary behaviors in relation to breast cancer risk: results from a case-control study among Polish-born women in the US
Azam Najaf Kouchak, Michigan State University, USA
   
13:25-13:45 Title: Identification and characterization of a novel selective HDAC6 inhibitor against triple negative breast cancer
Elisabetta Panza, University of Naples Federico, Italy
   
13:45-14:05 Title: How we do it: Songket suture technique for lying half cone dog ear
Nur Qodir, University of Sriwijaya, Indonesia
   
14:05-14:25 Title: Novel therapeutic approaches in development for hormone receptor-positive metastatic breast cancer      
Richard Baird, University of Cambridge, UK
   
14:25-14:45 Title: Optimizing the Patient Experience for Women with Disabilities in the Breast Imaging Clinic
Jamie Spoont, University of Miami-Miller School of Medicine, USA
   
14:45-15:05 Title: Multi-modal microscopy for treatment of breast cancer cells with zirconium-based nano-particles
Herbert Schneckenburger, Aalen University, Germany
   
15:05-15:25 Title: Toxicity, half-life and antitumor activity of phenyl 4-(2-oxo-3-alkylimidazolidin-1-yl)benzenesulfonates: A novel family of antimitotic CYP1A1-targeted prodrugs in murine models
Atziri Corin Chavez Alvarez, Inserm-Université Clermont-Auvergne, France
   
15:25-16:05 Title: Breast Cancer Eradication by Steroid Receptor Coactivator-3 Deleted Regulaotry T Cells
Sang Jun Han, Baylor College of Medicine, USA
   
16:05-16:25 Title: Minimally Invasive Breast Cancer: How to Find Early Breast Cancers
Harnoor Singh, University of Texas at Houston, USA
   
16:25-16:45 Title: Epigenetic aging phenotype: a tumor biomarker for cancer susceptibility
Jung Su Yon, University of California, USA
   
16:45-17:05 Title: TRAIL induces cytokine production via the NFkB2 pathway promoting neutrophil chemotaxis and neutrophil-mediated immune-suppression in triple negative breast cancer cells
Stanley Lipkowitz, National Cancer Institute, USA
   
17:05-17:25 Title: Mammography-based Longitudinal Breast Cancer Risk Prediction Using a Temporal Multi-Modal Feature Fusion Framework
Haoyan Ding, UCLA, USA
Closing Ceremony
If any one interested to attend the conference or to book your speaker slot, please send an email to   breastcancer@innovinc.org 

Download